R1 RCM Inc (RCM)
12.44
+0.12
(+1.02%)
USD |
NASDAQ |
May 17, 16:00
12.44
0.00 (0.00%)
Pre-Market: 20:00
R1 RCM Enterprise Value: 7.339B for May 17, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 17, 2024 | 7.339B |
| May 16, 2024 | 7.288B |
| May 15, 2024 | 7.368B |
| May 14, 2024 | 7.250B |
| May 13, 2024 | 7.137B |
| May 10, 2024 | 7.191B |
| May 09, 2024 | 7.271B |
| May 08, 2024 | 7.512B |
| May 07, 2024 | 7.347B |
| May 06, 2024 | 7.478B |
| May 03, 2024 | 7.349B |
| May 02, 2024 | 7.341B |
| May 01, 2024 | 7.303B |
| April 30, 2024 | 7.273B |
| April 29, 2024 | 7.299B |
| April 26, 2024 | 7.109B |
| April 25, 2024 | 7.076B |
| April 24, 2024 | 7.084B |
| April 23, 2024 | 7.046B |
| April 22, 2024 | 7.113B |
| April 19, 2024 | 7.147B |
| April 18, 2024 | 7.160B |
| April 17, 2024 | 7.214B |
| April 16, 2024 | 7.240B |
| April 15, 2024 | 7.290B |
| Date | Value |
|---|---|
| April 12, 2024 | 7.349B |
| April 11, 2024 | 7.480B |
| April 10, 2024 | 7.446B |
| April 09, 2024 | 7.517B |
| April 08, 2024 | 7.475B |
| April 05, 2024 | 7.349B |
| April 04, 2024 | 7.412B |
| April 03, 2024 | 7.433B |
| April 02, 2024 | 7.408B |
| April 01, 2024 | 7.387B |
| March 31, 2024 | 7.522B |
| March 28, 2024 | 6.889B |
| March 27, 2024 | 6.933B |
| March 26, 2024 | 6.933B |
| March 25, 2024 | 6.959B |
| March 22, 2024 | 6.933B |
| March 21, 2024 | 6.975B |
| March 20, 2024 | 6.996B |
| March 19, 2024 | 6.971B |
| March 18, 2024 | 7.005B |
| March 15, 2024 | 7.152B |
| March 14, 2024 | 7.215B |
| March 13, 2024 | 7.333B |
| March 12, 2024 | 7.370B |
| March 11, 2024 | 7.370B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
1.136B
Minimum
Mar 18 2020
12.67B
Maximum
Aug 08 2022
5.645B
Average
6.575B
Median
Enterprise Value Benchmarks
| Panamera Holdings Corp | 35.48M |
| Thermo Fisher Scientific Inc | 255.70B |
| Sotera Health Co | 5.164B |
| PetMed Express Inc | 47.43M |
| LENZ Therapeutics Inc | 204.21M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -35.10M |
| Revenue (Quarterly) | 603.90M |
| Total Expenses (Quarterly) | 562.00M |
| EPS Diluted (Quarterly) | -0.08 |
| Gross Profit Margin (Quarterly) | 17.60% |
| Profit Margin (Quarterly) | -5.81% |
| Earnings Yield | -0.60% |
| Operating Earnings Yield | 4.47% |
| Normalized Earnings Yield | 0.7339 |